WSJ: The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure

HeartWorks and Mayo Clinic launch a clinical trial that involves surgically injecting lab-grown cardiac tissue—sourced from the patients’ skin cells—in people with congenital heart disease.

Share the Post:

Related Posts

Dr. Tim Nelson, HeartWorks CEO, featured on the Before the Cure podcast episode cover art

HeartWorks Featured on Before the Cure

Did you know your medical records could help shape the future of CHD treatment? The Co-op at HeartWorks is a free, secure database where CHD patients can upload their records — putting their data directly in the hands of researchers working to develop better therapies. Co-op members are notified when they qualify for new clinical trials, and their data helps identify where gaps in care exist. If you’re living with CHD, joining the Co-op is one of the most powerful things you can do

Read More

The Co-op at HeartWorks: How CHD Patient Data Is Changing Heart Research

Did you know your medical records could help shape the future of CHD treatment? The Co-op at HeartWorks is a free, secure database where CHD patients can upload their records — putting their data directly in the hands of researchers working to develop better therapies. Co-op members are notified when they qualify for new clinical trials, and their data helps identify where gaps in care exist. If you’re living with CHD, joining the Co-op is one of the most powerful things you can do

Read More
HeartWorks lab robot automating patient-specific cell manufacturing for congenital heart disease research

HeartWorks Introduces Lab Robots to Advance Cell Manufacturing

HeartWorks uses six-axis robotic systems to automate portions of patient-specific cell manufacturing, including cell passaging. The robots are designed to perform highly precise, repeatable movements and are part of HeartWorks’ effort to explore how automation and advanced imaging can make personalized cell manufacturing more consistent, efficient, and scalable for congenital heart disease therapies.

Read More

Send A Message

This field is for validation purposes and should be left unchanged.
Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.